DE69705421D1 - 15-fluoro-prostaglandine als augendrucksenkende mittel - Google Patents

15-fluoro-prostaglandine als augendrucksenkende mittel

Info

Publication number
DE69705421D1
DE69705421D1 DE69705421T DE69705421T DE69705421D1 DE 69705421 D1 DE69705421 D1 DE 69705421D1 DE 69705421 T DE69705421 T DE 69705421T DE 69705421 T DE69705421 T DE 69705421T DE 69705421 D1 DE69705421 D1 DE 69705421D1
Authority
DE
Germany
Prior art keywords
fluoro
prostaglandine
eye pressure
lowing agent
lowing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69705421T
Other languages
English (en)
Other versions
DE69705421T2 (de
Inventor
G Klimko
R Hellberg
W Zinke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21854596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69705421(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of DE69705421D1 publication Critical patent/DE69705421D1/de
Application granted granted Critical
Publication of DE69705421T2 publication Critical patent/DE69705421T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69705421T 1996-11-12 1997-11-07 15-fluoro-prostaglandine als augendrucksenkende mittel Expired - Fee Related DE69705421T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3051996P 1996-11-12 1996-11-12
PCT/US1997/020671 WO1998021181A2 (en) 1996-11-12 1997-11-07 15-fluoro prostaglandins as ocular hypotensives

Publications (2)

Publication Number Publication Date
DE69705421D1 true DE69705421D1 (de) 2001-08-02
DE69705421T2 DE69705421T2 (de) 2002-05-16

Family

ID=21854596

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69705421T Expired - Fee Related DE69705421T2 (de) 1996-11-12 1997-11-07 15-fluoro-prostaglandine als augendrucksenkende mittel

Country Status (9)

Country Link
US (1) US6649653B1 (de)
EP (1) EP0938472B1 (de)
JP (1) JP4248022B2 (de)
AT (1) ATE202557T1 (de)
AU (1) AU5355498A (de)
CA (1) CA2269855A1 (de)
DE (1) DE69705421T2 (de)
ES (1) ES2159889T3 (de)
WO (1) WO1998021181A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69714274T3 (de) * 1996-09-17 2006-06-01 Asahi Glass Co., Ltd. Fluorierte prostaglandinderivate und medikamente
JP3480549B2 (ja) * 1996-12-26 2003-12-22 参天製薬株式会社 ジフルオロプロスタグランジン誘導体およびその用途
EP1159266B1 (de) 1999-03-05 2004-11-03 Duke University C-16 ungesätigte fp-selektive prostaglandin analoge
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
GB0112699D0 (en) * 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP3354643B1 (de) 2009-05-01 2020-10-28 Aerie Pharmaceuticals, Inc. Hemmer mit doppelmechanismus zur behandlung von erkrankungen
EP3461484B9 (de) 2013-03-15 2021-06-09 Aerie Pharmaceuticals, Inc. Dimesylate salze von 4-(3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl, kombinationen mit prostaglandinen und deren verwendung in der behandlung von augenkrankheiten
CN103601708B (zh) * 2013-12-11 2015-06-17 武汉武药科技有限公司 一种前列素药物杂质的制备方法
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
MX2019002396A (es) 2016-08-31 2019-07-08 Aerie Pharmaceuticals Inc Composiciones oftalmicas.
EP3609871A4 (de) 2017-03-31 2021-01-06 Aerie Pharmaceuticals, Inc. Aryl-cyclopropyl-amino-isochinolinyl-amidverbindungen
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425359A (en) 1975-03-12 1984-01-10 Farmitalia Carlo Erba Fluoro-prostaglandins and process for their preparation
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
US4599353A (en) 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
GB8324004D0 (en) * 1983-09-07 1983-10-12 Erba Farmitalia 16-fluoro-16 17-didehydro prostanoids
SU1256394A1 (ru) * 1984-04-24 1987-06-07 Институт Органического Синтеза Ан Латвсср Производные 15( @ + @ )-фтор-11,15-дидезоксипростагландина @ ,обладающие антиагрегационной активностью
ATE108330T1 (de) 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
US5321128A (en) 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
CA2030345C (en) 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
EP0561073B1 (de) 1992-03-19 2001-10-24 R-Tech Ueno Ltd. Behandlung von Augenhochdruck mit Betablockern und Prostansäurederivaten
DE4229050A1 (de) 1992-08-31 1994-03-03 Schering Ag Neue 9-Chlor-Prostaglandin-Ester und -amide
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
JPH0770054A (ja) 1993-08-30 1995-03-14 R Tec Ueno:Kk 生化学的拮抗および疾患処置剤
JPH1087607A (ja) 1996-09-17 1998-04-07 Asahi Glass Co Ltd 含フッ素プロスタグランジン誘導体の製造方法

Also Published As

Publication number Publication date
JP2001505556A (ja) 2001-04-24
JP4248022B2 (ja) 2009-04-02
US6649653B1 (en) 2003-11-18
ATE202557T1 (de) 2001-07-15
WO1998021181A3 (en) 1998-07-16
ES2159889T3 (es) 2001-10-16
EP0938472B1 (de) 2001-06-27
DE69705421T2 (de) 2002-05-16
WO1998021181A2 (en) 1998-05-22
AU5355498A (en) 1998-06-03
CA2269855A1 (en) 1998-05-22
EP0938472A2 (de) 1999-09-01

Similar Documents

Publication Publication Date Title
ATE273009T1 (de) Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel
DE69705421D1 (de) 15-fluoro-prostaglandine als augendrucksenkende mittel
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DE69923671D1 (de) Verwendung von kannabidiol als entzündunghemmende mittel
ES2127419T3 (es) Colorantes amarillos polimerizables y su uso en lentes oftalmicas.
BR9811012A (pt) "uso de um composto".
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
AU2059499A (en) Use of heterocyclic quaternary polyammonium polymers as protective agent for keratin fibres and cosmetic compositions
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
DE60008143D1 (de) Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
ATE203519T1 (de) Chinolinderivate als antimalariamittel
WO1998021182A3 (en) Use of cis-δ4 analogs of prostaglandins as ocular hypotensives
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
CY1106409T1 (el) Παραγωγα κινολινης
DE59508843D1 (en) 2-fluor-6-nitroaniline
ATE289198T1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
DE69837622D1 (de) Taurinderivate verwendbar in der behandlung von netzhauterkrankungen
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
BR9807959A (pt) Composição cosmética, utilização da associação de um poliuretano associativo não iÈnico e de um polìmero aniÈnico e processo de tratamento cosmético dos cabelos
MX9505180A (es) Uso de un antagonista de la substancia p para la obtencion de una composicion farmaceutica para el tratamiento de prurito y disestesias oculares o palpebrales.
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
PT1169026E (pt) Utilizacao de activadores de ap-1 no tratamento do glaucoma e da hipertensao ocular

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee